| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.5M | — | +116.7% |
| R&D Expense | $21.7M | -15.8% | -26.3% |
| SG&A Expense | $5.2M | -18.7% | -34.2% |
| Operating Income | -$20.4M | +36.6% | +40.6% |
| Net Income | -$19.7M | +36.8% | +38.9% |
| EPS (Basic) | -$0.26 | +36.6% | +39.5% |
| EPS (Diluted) | -$0.26 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.5M | +84.6% | +326.9% |
| Short-term Investments | $7.4M | -84.4% | -94.8% |
| Current Assets | $58.3M | -24.1% | -62.7% |
| Total Assets | $94.8M | -17.5% | -52.0% |
| Current Liabilities | $18.2M | -13.0% | -18.2% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$79.4M | — | — |
| Capital Expenditures | $67K | — | — |
| Investing Cash Flow | $113.8M | — | — |
| Financing Cash Flow | -$128K | — | — |
| Free Cash Flow | -$79.5M | — | — |
| +36.6% |
| +39.5% |
| $36.2M |
| -7.3% |
| -11.2% |
| Stockholders' Equity | $58.5M | -22.8% | -62.6% |